Platelet-to-high-density lipoprotein cholesterol ratio as a predictor of stroke risk: a longitudinal analysis of the China health and retirement longitudinal study

血小板/高密度脂蛋白胆固醇比值作为卒中风险预测指标:中国健康与退休纵向研究的纵向分析

阅读:1

Abstract

BACKGROUND: Stroke is a major health concern in aging populations. This study investigates the platelet-to-high-density lipoprotein cholesterol ratio (PHR) as a predictor of stroke risk in middle-aged and older Chinese adults. METHODS: We analyzed data from 8,405 participants aged ≥45 years in the China Health and Retirement Longitudinal Study (CHARLS), with an 8-year follow-up. PHR was calculated from baseline blood samples. Multivariate logistic regression models, supplemented by smooth curve fitting to assess dose-response relationships and subgroup analyses with interaction testing, assessed the association between PHR and stroke incidence, adjusting for various factors. RESULTS: During follow-up, 753 (8.96%) participants reported a stroke. Smooth curve fitting visually confirmed a linear dose-response relationship between PHR and stroke probability. Each standard deviation increase in PHR was associated with 17% higher odds of stroke (OR: 1.17; 95% CI: 1.08-1.26, p < 0.05). The highest PHR quartile had 42% higher odds of stroke compared to the lowest (OR: 1.42; 95% CI: 1.14-1.76, p = 0.002), with a significant trend across quartiles (p < 0.05). CONCLUSION: Elevated PHR is independently associated with increased stroke risk in middle-aged and older Chinese adults. Incorporating PHR into existing risk assessment tools may enhance stroke risk stratification and guide preventive strategies. Further research is needed to elucidate underlying mechanisms and validate findings in diverse populations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。